MRPS14
geneOn this page
Also known as HSMRPS14uS14m
Summary
MRPS14 (mitochondrial ribosomal protein S14, HGNC:14049) is a protein-coding gene on chromosome 1q25.1, encoding Small ribosomal subunit protein uS14m (O60783). It is a selective cancer dependency (DepMap: 68.2% of cell lines).
Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical properties, which prevents easy recognition by sequence homology. This gene encodes a 28S subunit protein that belongs to the ribosomal protein S14P family. Alternative splicing results in multiple transcript variants.
Source: NCBI Gene 63931 — RefSeq curated summary.
At a glance
- Gene–disease (curated): combined oxidative phosphorylation deficiency 38 (Moderate, GenCC) — +1 more curated relationship
- GWAS associations: 3
- Clinical variants (ClinVar): 57 total — 2 pathogenic
- Phenotypes (HPO): 22
- Cancer dependency (DepMap): dependent in 68.2% of screened cell lines
- MANE Select transcript:
NM_022100
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14049 |
| Approved symbol | MRPS14 |
| Name | mitochondrial ribosomal protein S14 |
| Location | 1q25.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HSMRPS14, uS14m |
| Ensembl gene | ENSG00000120333 |
| Ensembl biotype | protein_coding |
| OMIM | 611978 |
| Entrez | 63931 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 3 protein_coding, 1 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000367677, ENST00000476371, ENST00000498253, ENST00000881843, ENST00000915397
RefSeq mRNA: 1 — MANE Select: NM_022100
NM_022100
CCDS: CCDS1316
Canonical transcript exons
ENST00000476371 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001445354 | 175023364 | 175023425 |
| ENSE00001928201 | 175012958 | 175014851 |
| ENSE00003551304 | 175018418 | 175018576 |
Expression profiles
Bgee: expression breadth ubiquitous, 287 present calls, max score 95.64.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 41.6284 / max 448.9475, expressed in 1813 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 15986 | 41.1725 | 1813 |
| 15985 | 0.4559 | 221 |
Top tissues by expression
294 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| tendon of biceps brachii | UBERON:0008188 | 95.64 | gold quality |
| endothelial cell | CL:0000115 | 94.38 | gold quality |
| oocyte | CL:0000023 | 92.83 | gold quality |
| secondary oocyte | CL:0000655 | 92.80 | gold quality |
| triceps brachii | UBERON:0001509 | 92.64 | gold quality |
| medial globus pallidus | UBERON:0002477 | 92.19 | gold quality |
| parotid gland | UBERON:0001831 | 92.15 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 91.87 | gold quality |
| islet of Langerhans | UBERON:0000006 | 91.73 | gold quality |
| heart right ventricle | UBERON:0002080 | 91.59 | gold quality |
| tendon | UBERON:0000043 | 91.48 | gold quality |
| gluteal muscle | UBERON:0002000 | 91.37 | gold quality |
| parietal pleura | UBERON:0002400 | 91.32 | gold quality |
| periodontal ligament | UBERON:0008266 | 91.18 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 90.89 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 90.75 | gold quality |
| spinal cord | UBERON:0002240 | 90.57 | gold quality |
| deltoid | UBERON:0001476 | 90.50 | gold quality |
| adrenal tissue | UBERON:0018303 | 90.49 | gold quality |
| pleura | UBERON:0000977 | 90.27 | gold quality |
| pancreatic ductal cell | CL:0002079 | 90.19 | gold quality |
| right adrenal gland | UBERON:0001233 | 89.99 | gold quality |
| colonic epithelium | UBERON:0000397 | 89.86 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 89.82 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 89.76 | gold quality |
| calcaneal tendon | UBERON:0003701 | 89.75 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 89.60 | gold quality |
| epithelium of esophagus | UBERON:0001976 | 89.59 | gold quality |
| pancreas | UBERON:0001264 | 89.57 | gold quality |
| left adrenal gland | UBERON:0001234 | 89.43 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
71 targeting MRPS14, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-513A-5P | 100.00 | 69.77 | 2465 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-12118 | 100.00 | 65.88 | 1270 |
| HSA-MIR-3924 | 100.00 | 72.09 | 2394 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-513B-5P | 99.99 | 69.96 | 2150 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-27B-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-9985 | 99.98 | 72.11 | 2939 |
| HSA-MIR-3173-3P | 99.98 | 66.49 | 1217 |
| HSA-MIR-6891-5P | 99.98 | 66.53 | 1372 |
| HSA-MIR-8068 | 99.98 | 73.85 | 2376 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-539-3P | 99.98 | 70.74 | 1616 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-146A-5P | 99.96 | 68.93 | 988 |
| HSA-MIR-146B-5P | 99.96 | 69.13 | 977 |
| HSA-MIR-7153-5P | 99.94 | 68.89 | 1006 |
| HSA-MIR-218-5P | 99.93 | 72.22 | 2103 |
| HSA-MIR-4779 | 99.86 | 66.50 | 1583 |
| HSA-MIR-5582-3P | 99.86 | 72.48 | 4221 |
| HSA-MIR-4420 | 99.82 | 70.08 | 1624 |
| HSA-MIR-181B-2-3P | 99.81 | 70.06 | 1646 |
| HSA-MIR-181B-3P | 99.81 | 70.06 | 1646 |
| HSA-MIR-4320 | 99.75 | 65.80 | 793 |
| HSA-MIR-3059-5P | 99.70 | 69.93 | 2491 |
| HSA-MIR-4677-5P | 99.70 | 70.09 | 1940 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 68.2% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 1)
- our data demonstrate pathogenic mutations in MRPS14 can manifest as a perinatal-onset mitochondrial hypertrophic cardiomyopathy with a novel molecular pathogenic mechanism that impairs the function of mitochondrial ribosomes during translation elongation or mitochondrial mRNA recruitment rather than assembly. (PMID:30358850)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | mrps14 | ENSDARG00000068305 |
| mus_musculus | Mrps14 | ENSMUSG00000058267 |
| rattus_norvegicus | Mrps14 | ENSRNOG00000079901 |
| drosophila_melanogaster | mRpS14 | FBGN0044030 |
| caenorhabditis_elegans | WBGENE00011334 |
Protein
Protein identifiers
Small ribosomal subunit protein uS14m — O60783 (reviewed: O60783)
Alternative names: 28S ribosomal protein S14, mitochondrial
All UniProt accessions (2): O60783, F2Z361
UniProt curated annotations — full annotation on UniProt →
Subunit / interactions. Component of the mitochondrial small ribosomal subunit (mt-SSU). Mature mammalian 55S mitochondrial ribosomes consist of a small (28S) and a large (39S) subunit. The 28S small subunit contains a 12S ribosomal RNA (12S mt-rRNA) and 30 different proteins. The 39S large subunit contains a 16S rRNA (16S mt-rRNA), a copy of mitochondrial valine transfer RNA (mt-tRNA(Val)), which plays an integral structural role, and 52 different proteins. Interacts with LIAT1.
Subcellular location. Mitochondrion.
Disease relevance. Combined oxidative phosphorylation deficiency 38 (COXPD38) [MIM:618378] An autosomal recessive disorder due to mitochondrial dysfunction and characterized by perinatal hypertrophic cardiomyopathy, growth retardation, muscle hypotonia, elevated lactate, dysmorphy and intellectual disability. The disease may be caused by variants affecting the gene represented in this entry.
Similarity. Belongs to the universal ribosomal protein uS14 family.
RefSeq proteins (1): NP_071383* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001209 | Ribosomal_uS14 | Family |
Pfam: PF00253
UniProt features (13 total): helix 6, strand 3, turn 2, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
77 structures, top 30 by resolution.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7QI4 | ELECTRON MICROSCOPY | 2.21 |
| 8CSS | ELECTRON MICROSCOPY | 2.36 |
| 7P2E | ELECTRON MICROSCOPY | 2.4 |
| 8RRI | ELECTRON MICROSCOPY | 2.4 |
| 9OLF | ELECTRON MICROSCOPY | 2.46 |
| 9OJM | ELECTRON MICROSCOPY | 2.5 |
| 8CSQ | ELECTRON MICROSCOPY | 2.54 |
| 8CSR | ELECTRON MICROSCOPY | 2.54 |
| 6ZM6 | ELECTRON MICROSCOPY | 2.59 |
| 7QI5 | ELECTRON MICROSCOPY | 2.63 |
| 8CSP | ELECTRON MICROSCOPY | 2.66 |
| 7PNX | ELECTRON MICROSCOPY | 2.76 |
| 8ANY | ELECTRON MICROSCOPY | 2.85 |
| 8CST | ELECTRON MICROSCOPY | 2.85 |
| 6ZM5 | ELECTRON MICROSCOPY | 2.89 |
| 7PO0 | ELECTRON MICROSCOPY | 2.9 |
| 8K2A | ELECTRON MICROSCOPY | 2.9 |
| 9PGL | ELECTRON MICROSCOPY | 2.9 |
| 7PO1 | ELECTRON MICROSCOPY | 2.92 |
| 7PO3 | ELECTRON MICROSCOPY | 2.92 |
| 9PGF | ELECTRON MICROSCOPY | 2.93 |
| 6VMI | ELECTRON MICROSCOPY | 2.96 |
| 6RW4 | ELECTRON MICROSCOPY | 2.97 |
| 6VLZ | ELECTRON MICROSCOPY | 2.97 |
| 7QI6 | ELECTRON MICROSCOPY | 2.98 |
| 8QRN | ELECTRON MICROSCOPY | 2.98 |
| 9PSM | ELECTRON MICROSCOPY | 2.98 |
| 8OIS | ELECTRON MICROSCOPY | 3 |
| 9G5C | ELECTRON MICROSCOPY | 3 |
| 9G5D | ELECTRON MICROSCOPY | 3 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O60783-F1 | 87.18 | 0.79 |
Function
Pathways and Gene Ontology
Reactome pathways
7 pathways
| ID | Pathway |
|---|---|
| R-HSA-5368286 | Mitochondrial translation initiation |
| R-HSA-5389840 | Mitochondrial translation elongation |
| R-HSA-5419276 | Mitochondrial translation termination |
| R-HSA-9937383 | Mitochondrial ribosome-associated quality control |
| R-HSA-392499 | Metabolism of proteins |
| R-HSA-5368287 | Mitochondrial translation |
| R-HSA-72766 | Translation |
MSigDB gene sets: 184 (showing top):
BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN, GOBP_MITOCHONDRIAL_TRANSLATION, GOBP_TRANSLATION, MILI_PSEUDOPODIA_HAPTOTAXIS_UP, GOMF_STRUCTURAL_CONSTITUENT_OF_RIBOSOME, GOCC_MITOCHONDRIAL_ENVELOPE, LAIHO_COLORECTAL_CANCER_SERRATED_UP, OSMAN_BLADDER_CANCER_DN, GOCC_RIBOSOME, GOCC_SMALL_RIBOSOMAL_SUBUNIT, GOCC_ORGANELLAR_RIBOSOME, GOCC_MITOCHONDRIAL_MATRIX, GOCC_ORGANELLE_INNER_MEMBRANE, SANSOM_APC_TARGETS, GOCC_RIBOSOMAL_SUBUNIT
GO Biological Process (2): translation (GO:0006412), mitochondrial translation (GO:0032543)
GO Molecular Function (3): RNA binding (GO:0003723), structural constituent of ribosome (GO:0003735), protein binding (GO:0005515)
GO Cellular Component (8): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), mitochondrial ribosome (GO:0005761), mitochondrial small ribosomal subunit (GO:0005763), nuclear membrane (GO:0031965), cytoplasm (GO:0005737), ribosome (GO:0005840), ribonucleoprotein complex (GO:1990904)
Reactome top-level categories
Rollup of top-3 pathways:
| Category | Pathways |
|---|---|
| Mitochondrial translation | 4 |
| Translation | 1 |
| Metabolism of proteins | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| peptidyltransferase activity | 1 |
| translational initiation | 1 |
| translational elongation | 1 |
| translational termination | 1 |
| macromolecule biosynthetic process | 1 |
| protein metabolic process | 1 |
| protein biosynthetic process | 1 |
| mitochondrion | 1 |
| translation | 1 |
| mitochondrial gene expression | 1 |
| nucleic acid binding | 1 |
| structural molecule activity | 1 |
| ribosome | 1 |
| binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| organellar ribosome | 1 |
| mitochondrial matrix | 1 |
| organellar small ribosomal subunit | 1 |
| mitochondrial ribosome | 1 |
| mitochondrial protein-containing complex | 1 |
| nucleus | 1 |
| nuclear envelope | 1 |
| organelle membrane | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| intracellular membraneless organelle | 1 |
| protein-containing complex | 1 |
Protein interactions and networks
STRING
3257 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MRPS14 | MRPL44 | Q9H9J2 | 687 |
| MRPS14 | MRPS25 | P82663 | 665 |
| MRPS14 | MRPL24 | Q96A35 | 644 |
| MRPS14 | MRPS18C | Q9Y3D5 | 640 |
| MRPS14 | MRPS27 | Q92552 | 632 |
| MRPS14 | MRPS11 | P82912 | 617 |
| MRPS14 | MRPS2 | Q9Y399 | 615 |
| MRPS14 | MRPS9 | P82933 | 607 |
| MRPS14 | MRPS10 | P82664 | 604 |
| MRPS14 | MRPS7 | Q9Y2R9 | 599 |
| MRPS14 | MRPL21 | Q7Z2W9 | 594 |
| MRPS14 | MRPS18A | Q9NVS2 | 586 |
| MRPS14 | MRPL55 | Q7Z7F7 | 577 |
| MRPS14 | OASL | Q15646 | 568 |
| MRPS14 | ZNF707 | Q96C28 | 567 |
IntAct
158 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| YBX1 | HNRNPR | psi-mi:“MI:0914”(association) | 0.770 |
| CFTR | ESYT2 | psi-mi:“MI:2364”(proximity) | 0.710 |
| ERBB3 | PIK3R2 | psi-mi:“MI:0914”(association) | 0.700 |
| MRPS27 | MRPS14 | psi-mi:“MI:0914”(association) | 0.640 |
| LIN28A | IGF2BP3 | psi-mi:“MI:0914”(association) | 0.640 |
| FAM120A | SYNCRIP | psi-mi:“MI:0914”(association) | 0.640 |
| MRPS14 | FGFR3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MRPS14 | GSN | psi-mi:“MI:0915”(physical association) | 0.560 |
| MRPS14 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| UBQLN1 | MRPS14 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MRPS15 | MRPS14 | psi-mi:“MI:0914”(association) | 0.530 |
| RPL6 | MRPS14 | psi-mi:“MI:0914”(association) | 0.530 |
| TRMT10B | MRPS14 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS18B | MRPS14 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS18C | MRPS14 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPL18 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS34 | MRPS12 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPS11 | MRPS14 | psi-mi:“MI:0914”(association) | 0.530 |
BioGRID (275): MRPS14 (Affinity Capture-MS), MRPS14 (Affinity Capture-MS), MRPS14 (Affinity Capture-MS), MRPS14 (Affinity Capture-MS), MRPS14 (Affinity Capture-MS), MRPS14 (Affinity Capture-MS), MRPS14 (Affinity Capture-MS), MRPS14 (Affinity Capture-MS), MRPS14 (Co-fractionation), RPS2 (Co-fractionation), MRPS14 (Affinity Capture-MS), MRPS14 (Affinity Capture-MS), MRPS14 (Affinity Capture-MS), MRPS14 (Affinity Capture-MS), MRPS14 (Affinity Capture-MS)
ESM2 similar proteins: A0AJY7, B1VKG7, O60783, P56556, P82915, P82920, P82933, Q02366, Q0MQA3, Q0MQA4, Q0MQA5, Q0VFH6, Q13084, Q19V89, Q1JQ99, Q29IK4, Q2HJJ1, Q2TA12, Q2TBR2, Q3T040, Q3T0J3, Q498T4, Q58DQ5, Q58DV5, Q5I0K8, Q5T653, Q5U4Z8, Q5ZMU0, Q6B860, Q6DDY9, Q6P1L8, Q71YD4, Q7M0E7, Q7SF85, Q7ZUH5, Q80X85, Q8MFA1, Q8Y620, Q92AC7, Q9BYC9
Diamond homologs: A0AJY7, A0M585, A1B040, A1TYL0, A3PGM4, A4WVJ5, A4X8U4, A5FN08, A5ISL8, A5UDT4, A5UHU4, A5VQZ3, A5WCK3, A6GZ86, A6KYI2, A6QGN8, A6U1F6, A6X0D1, A7HWS4, A7X1Z0, A7Z2Q4, A8FI98, A8M6L1, A9IHT7, A9M5N7, B0B913, B0BAP2, B0CH19, B0U5L2, B0UX27, B2I8I2, B2S666, B3CN39, B4R8N0, B6IRR9, O31587, O60783, O84792, P05716, P14875
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| MRPS14 | “form complex” | “28S mitochondrial small ribosomal subunit” | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 165 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Mitochondrial translation | 21 | 24.3× | 8e-22 |
| Mitochondrial translation initiation | 22 | 23.5× | 3e-22 |
| Mitochondrial translation elongation | 22 | 23.5× | 3e-22 |
| Mitochondrial ribosome-associated quality control | 22 | 22.7× | 4e-22 |
| Mitochondrial translation termination | 22 | 20.3× | 4e-21 |
| Translation | 24 | 12.5× | 5e-18 |
| Peptide chain elongation | 9 | 9.6× | 1e-05 |
| Viral mRNA Translation | 9 | 9.6× | 1e-05 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| mitochondrial translation | 22 | 25.8× | 2e-22 |
| translation | 20 | 13.9× | 7e-15 |
| cytoplasmic translation | 10 | 12.5× | 2e-06 |
| mRNA stabilization | 5 | 12.4× | 4e-03 |
| negative regulation of translation | 8 | 10.6× | 2e-04 |
| regulation of alternative mRNA splicing, via spliceosome | 6 | 9.9× | 3e-03 |
| RNA processing | 6 | 8.9× | 4e-03 |
| mRNA splicing, via spliceosome | 10 | 6.2× | 7e-04 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
57 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 2 |
| Likely pathogenic | 0 |
| Uncertain significance | 39 |
| Likely benign | 11 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (2)
| Variant ID | HGVS | Classification |
|---|---|---|
| 4688188 | D37N | Pathogenic |
| 4688189 | MRPS14, ASN60ASP | Pathogenic |
SpliceAI
274 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:175018403:T:C | donor_gain | 1.0000 |
| 1:175018412:GCTAA:G | donor_loss | 1.0000 |
| 1:175018413:CTAA:C | donor_loss | 1.0000 |
| 1:175018414:TAA:T | donor_loss | 1.0000 |
| 1:175018415:AACC:A | donor_loss | 1.0000 |
| 1:175018416:ACCTG:A | donor_loss | 1.0000 |
| 1:175018447:T:A | donor_gain | 1.0000 |
| 1:175018447:T:TA | donor_loss | 1.0000 |
| 1:175018467:AG:A | donor_gain | 1.0000 |
| 1:175018467:AGC:A | donor_gain | 1.0000 |
| 1:175018468:G:C | donor_gain | 1.0000 |
| 1:175018476:T:C | donor_gain | 1.0000 |
| 1:175018573:CCAT:C | acceptor_gain | 1.0000 |
| 1:175018574:CAT:C | acceptor_gain | 1.0000 |
| 1:175018574:CATC:C | acceptor_gain | 1.0000 |
| 1:175018576:TC:T | acceptor_loss | 1.0000 |
| 1:175018577:CTGAA:C | acceptor_loss | 1.0000 |
| 1:175018578:T:G | acceptor_loss | 1.0000 |
| 1:175014848:CATC:C | acceptor_gain | 0.9900 |
| 1:175018448:C:A | donor_gain | 0.9900 |
| 1:175018467:A:AC | donor_gain | 0.9900 |
| 1:175018467:AGCCT:A | donor_gain | 0.9900 |
| 1:175018572:ACCAT:A | acceptor_gain | 0.9900 |
| 1:175018573:CCATC:C | acceptor_gain | 0.9900 |
| 1:175018575:AT:A | acceptor_gain | 0.9900 |
| 1:175018577:C:CC | acceptor_gain | 0.9900 |
| 1:175023358:CCTGA:C | donor_loss | 0.9700 |
| 1:175023359:CTGAC:C | donor_loss | 0.9700 |
| 1:175023360:TGA:T | donor_loss | 0.9700 |
| 1:175023361:GAC:G | donor_loss | 0.9700 |
AlphaMissense
822 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:175014735:A:C | S107R | 0.992 |
| 1:175014735:A:T | S107R | 0.992 |
| 1:175014737:T:G | S107R | 0.992 |
| 1:175014810:G:C | S82R | 0.992 |
| 1:175014810:G:T | S82R | 0.992 |
| 1:175014812:T:G | S82R | 0.992 |
| 1:175018500:C:G | R41P | 0.991 |
| 1:175014674:A:G | W128R | 0.990 |
| 1:175014674:A:T | W128R | 0.990 |
| 1:175014736:C:A | S107I | 0.990 |
| 1:175014844:G:T | A71D | 0.990 |
| 1:175018469:C:A | R51S | 0.989 |
| 1:175018469:C:G | R51S | 0.989 |
| 1:175014746:A:G | W104R | 0.988 |
| 1:175014746:A:T | W104R | 0.988 |
| 1:175014712:G:T | A115D | 0.987 |
| 1:175018448:C:A | R58S | 0.987 |
| 1:175018448:C:G | R58S | 0.987 |
| 1:175014691:C:T | G122E | 0.984 |
| 1:175018513:C:G | D37H | 0.984 |
| 1:175018515:C:G | R36P | 0.984 |
| 1:175014785:A:G | C91R | 0.983 |
| 1:175018449:C:G | R58T | 0.983 |
| 1:175014772:G:A | S95F | 0.981 |
| 1:175018456:A:G | S56P | 0.981 |
| 1:175014672:C:A | W128C | 0.980 |
| 1:175014672:C:G | W128C | 0.980 |
| 1:175018464:C:G | R53P | 0.980 |
| 1:175014713:C:G | A115P | 0.979 |
| 1:175018502:T:A | R40S | 0.978 |
dbSNP variants (sampled 300 via entrez): RS1000049825 (1:175012653 A>G), RS1000660074 (1:175019913 G>T), RS1000692402 (1:175024276 A>C), RS1000933412 (1:175013435 T>TAATC), RS1001201278 (1:175025065 A>G), RS1001834497 (1:175018326 T>C), RS1002876432 (1:175023589 C>A), RS1003101377 (1:175016958 G>A), RS1003117325 (1:175016738 T>C,G), RS1003212673 (1:175021817 T>C), RS1003221601 (1:175021944 T>A), RS1003563031 (1:175016786 G>A), RS1003854129 (1:175015420 C>T), RS1003947697 (1:175016694 G>T), RS1003999978 (1:175016239 G>A,T)
Disease associations
OMIM: gene MIM:611978 | disease phenotypes: MIM:618378
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| combined oxidative phosphorylation deficiency 38 | Moderate | Autosomal recessive |
ClinGen Gene-Disease Validity (1)
Expert-panel classifications — Definitive > Strong > Moderate > Limited > Disputed > Refuted.
| Disease | Classification | Inheritance |
|---|---|---|
| mitochondrial disease | Limited | AR |
Mondo (1): combined oxidative phosphorylation deficiency 38 (MONDO:0032712)
Orphanet (0):
HPO phenotypes
22 total (22 of 22 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000007 | Autosomal recessive inheritance |
| HP:0000316 | Hypertelorism |
| HP:0000358 | Posteriorly rotated ears |
| HP:0000369 | Low-set ears |
| HP:0000750 | Delayed speech and language development |
| HP:0001263 | Global developmental delay |
| HP:0001290 | Generalized hypotonia |
| HP:0001508 | Failure to thrive |
| HP:0001639 | Hypertrophic cardiomyopathy |
| HP:0001716 | Wolff-Parkinson-White syndrome |
| HP:0002093 | Respiratory insufficiency |
| HP:0002151 | Increased circulating lactate concentration |
| HP:0003128 | Lactic acidosis |
| HP:0003348 | Hyperalaninemia |
| HP:0005280 | Depressed nasal bridge |
| HP:0008322 | Abnormal mitochondrial morphology |
| HP:0008347 | Decreased activity of mitochondrial complex IV |
| HP:0011800 | Midface retrusion |
| HP:0011923 | Decreased activity of mitochondrial complex I |
| HP:0011924 | Decreased activity of mitochondrial complex III |
| HP:0011925 | Decreased activity of mitochondrial ATP synthase complex |
| HP:0031936 | Delayed ability to walk |
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010988_261 | Adult body size | 8.000000e-10 |
| GCST90002400_527 | Plateletcrit | 7.000000e-09 |
| GCST90013442_2 | Keratoconus | 3.000000e-09 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0007985 | platelet crit |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
38 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | increases expression, affects expression | 2 |
| p-Chloromercuribenzoic Acid | affects cotreatment, decreases expression | 2 |
| aristolochic acid I | decreases expression | 1 |
| bisphenol F | affects cotreatment, increases expression | 1 |
| dicrotophos | decreases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | increases expression | 1 |
| trichostatin A | increases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| cobaltous chloride | decreases expression | 1 |
| ochratoxin A | decreases expression, affects cotreatment | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| K 7174 | decreases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | decreases expression, affects cotreatment | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Acetaminophen | affects cotreatment, increases expression | 1 |
| Air Pollutants | affects expression, increases abundance | 1 |
| Atrazine | decreases expression | 1 |
| Cadmium | increases expression | 1 |
| Carbamazepine | affects expression | 1 |
| Citrinin | affects cotreatment, decreases expression | 1 |
| Dexamethasone | affects cotreatment, increases expression | 1 |
| Enzyme Inhibitors | decreases activity, increases O-linked glycosylation | 1 |
| Hydrogen Peroxide | increases expression | 1 |
| Indomethacin | affects cotreatment, increases expression | 1 |
| Lipopolysaccharides | increases expression, affects cotreatment | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Associated diseases: combined oxidative phosphorylation deficiency 38, mitochondrial disease
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): combined oxidative phosphorylation deficiency 38, keratoconus